10.3390/jpm13040626 38 GandasiN
Keywords: bone loss, heart function, semaglutide, vertical sleeve gastrectomy, weight loss INTRODUCTION Obesity represents a significant public health challenge, with its prevalence sharply increasing worldwide, contributing to numerous comorbidities, including cardiovascular diseases, type 2 diabetes (T2D), and various types of cancers (14)
Desai, National Institute of Neurological Disorders and Stroke (NIH), United States Reviewed by Devon L
BMI 27 with weight-related conditions, such as: Type 2 diabetes or prediabetes Hypertension High cholesterol Sleep apnea Fatty liver disease (NAFLD) PCOS Insulin resistance Patients in this range may be candidates because GLP-1 medications act on pathways related to blood sugar, appetite, and metabolic regulation
Many people find their optimal response at 5 mg, 7.5 mg, or 10 mg
Some of the symptoms and signs of social anhedonia include : Social withdrawal Lack of interest in socializing Difficulty or inability to feel pleasure or happiness in social situations Emotional numbness Feeling disconnected from others Difficulty expressing emotions Not having or losing social relationships Being completely uninterested in spending time with other people Physical anhedonia symptoms Physical anhedonia is the inability to feel interested in physical activities that typically bring pleasure, like eating and sexual activities
